Literature DB >> 11710920

Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses.

I L Boxman1, A Russell, L H Mulder, J N Bavinck, J ter Schegget, A Green.   

Abstract

Epidermodysplasia-verruciformis-associated human papillomavirus DNA has been demonstrated in squamous cell carcinomas and plucked hair from immunocompetent patients and renal transplant recipients. This study investigated the association between infection with epidermodysplasia-verruciformis-associated human papillomavirus, identified by the detection of viral DNA in plucked eyebrow hairs, and solar keratoses. These lesions are strongly predictive of squamous cell carcinoma. In a cross-sectional study 518 individuals were enrolled from a randomly selected sample of a subtropical Australian community. Epidermodysplasia-verruciformis-associated human papillomavirus DNA in eyebrow hair was detected using a nested polymerase chain reaction specific for epidermodysplasia-verruciformis-associated human papillomavirus types. Epidermo dysplasia-verruciformis-associated human papillomavirus DNA was present in 121 (49%) of 245 men and 116 (44%) of 262 women. There was a strongly significant increase in epidermodysplasia-verruciformis-associated human papillomavirus infection with age (p < 0.00001), with prevalences of 29% in the 25-39 y age group, 42% at 40-59 y and 65% in the 60-79 y age group. Among men there was a strong association between epidermodysplasia-verruciformis-associated human papillomavirus and solar keratoses with an odds ratio, adjusted for age, skin color, and occupational sun exposure, of 3.40 (95% confidence interval, 1.77-6.53). No such association was found among women [odds ratio 1.03 (95% confidence interval 0.59-1.77, after adjustment for the same factors)]. Differences in occupational sun exposure and smoking histories could not explain these apparently different associations between epidermodysplasia-verruciformis-associated human papillomavirus infection and solar keratoses in men and women. In conclusion, epidermodysplasia-verruciformis-associated human papillomavirus infection is associated with solar keratoses in men suggesting that epidermodysplasia-verruciformis-associated human papillomavirus infection, in conjunction with sex specific factors (like androgens), may be involved in neoplastic changes of keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710920     DOI: 10.1046/j.1523-1747.2001.01499.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study.

Authors:  Rossybelle P Amorrortu; Neil A Fenske; Basil S Cherpelis; Laxmi Vijayan; Yayi Zhao; Juliana Balliu; Jane L Messina; Vernon K Sondak; Anna R Giuliano; Tim Waterboer; Michael Pawlita; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-19       Impact factor: 4.254

2.  Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study.

Authors:  Shams Rahman; Christine M Pierce Campbell; Tim Waterboer; Dana E Rollison; Donna J Ingles; B Nelson Torres; Angelika Michel; Staci L Sudenga; Michael Pawlita; Luisa L Villa; Eduardo Lazcano Ponce; Amy R Borenstein; Wei Wang; Anna R Giuliano
Journal:  J Gen Virol       Date:  2016-10-06       Impact factor: 3.891

3.  Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.

Authors:  Sönke Weissenborn; Rachel E Neale; Tim Waterboer; Damiano Abeni; Jan Nico Bouwes Bavinck; Adele C Green; Catherine A Harwood; Sylvie Euvrard; Mariet C W Feltkamp; Maurits N C de Koning; Luigi Naldi; Wim G V Quint; Gianpaolo Tessari; Charlotte M Proby; Ulrike Wieland; Herbert Pfister
Journal:  Med Microbiol Immunol       Date:  2011-07-27       Impact factor: 3.402

4.  Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA.

Authors:  Maurits de Koning; Wim Quint; Linda Struijk; Bernhard Kleter; Patrick Wanningen; Leen-Jan van Doorn; Sönke Jan Weissenborn; Mariet Feltkamp; Jan ter Schegget
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients.

Authors:  Wei Li; Carol H Thompson; Ding Xin; Yvonne E Cossart; Christopher J O'Brien; Edward B McNeil; Kan Gao; Richard A Scolyer; Barbara R Rose
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

6.  [Low-dose prophylactic oral isotretinoin treatment for 18 years in a patient with epidermodysplasia verruciformis and numerous squamous cell carcinomas].

Authors:  Svetoslava Troyanova-Slavkova; Lena Eickenscheidt; Jörg-Martin Pönnighaus; Lutz Kowalzick
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

7.  Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma.

Authors:  Sarah T Arron; J Graham Ruby; Eric Dybbro; Don Ganem; Joseph L Derisi
Journal:  J Invest Dermatol       Date:  2011-04-14       Impact factor: 8.551

8.  Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.

Authors:  Karin J Purdie; Thirunavukarasu Surentheran; Jane C Sterling; Louise Bell; Jane M McGregor; Charlotte M Proby; Catherine A Harwood; Judith Breuer
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

9.  Seroprevalence of 34 human papillomavirus types in the German general population.

Authors:  Kristina M Michael; Tim Waterboer; Peter Sehr; Annette Rother; Ulrich Reidel; Heiner Boeing; Ignacio G Bravo; Jörg Schlehofer; Barbara C Gärtner; Michael Pawlita
Journal:  PLoS Pathog       Date:  2008-06-20       Impact factor: 6.823

10.  Morphological Spectrum of Orbitoocular Diseases in a Tertiary Health Centre in Keffi, North Central Nigeria.

Authors:  Ifeyinwa Mary Onwubuya; Tunde Mark Owoyele; Olaejirinde Olaniyi Olaofe; Kevin Nwabueze Ezike
Journal:  Adv Med       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.